BD (NYSE:BDX) announced recently that it inaugurated a new $38.6 million manufacturing facility in Tijuana, Mexico.
Government officials from Mexico and the state of Baja California joined in the opening of the medication management plant. BD plans for the facility to produce devices and technologies that improve medication safety within healthcare settings.
According to a news release, the facility spans 15,775 square meters. The company expects to add 500 new jobs there over the next two years.
In the first phase, BD plans to create 75 jobs responsible for manufacturing automated dispensing cabinets that dispense medication to patients. Also, the company intends to export these devices to North America, Europe, Africa and Asia countries.
“Our new facility in Tijuana is BD’s 12th manufacturing plant in Mexico and is a testament to our commitment to Mexico and the strong relationship we’ve built in communities across the country over the past 65 years,” said Julio Duclos, VP and general director of Mexico, the Caribbean and Central America for BD. “The 17,000 BD employees in Mexico are focused on producing high-quality medical devices that are used by health care providers and patients around the world. We look forward to continuing to grow in Mexico.”
BD continues to expand medication facilities
BD said its expansion in Tijuana represents a four-year strategic investment plan. As part of the plan, the company intends to invest $1.2 billion to expand and upgrade technology and production capacity worldwide, including in Mexico. Just over one year ago, the company broke ground on its $200 million pre-filled drug delivery device manufacturing plant in Spain.
Eventually, BD plans to build upon its six existing sites in Columbus, Nebraska; Cuautitlán, Mexico; Fukushima, Japan; Le Pont-de-Claix, France; Swindon, United Kingdom; and Tatabánya, Hungary.
